Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roland W Sutter

Showing results (121-130 of 130) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 130 results.
The Journal of Infectious Diseases|November 24, 2020
Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian ChildrenBeckie N Tagbo, Harish Verma, Zubairu M Mahmud, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modelingKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 19, 2012
Expert review on poliovirus immunity and transmissionRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
The Journal of Infectious Diseases|November 12, 2020
Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, MozambiqueNilsa de Deus, Igor Paulo Ubisse Capitine, Adilson Fernando Loforte Bauhofer, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 5, 2013
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needsRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
The Journal of Infectious Diseases|February 25, 2016
Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011-2014Kehinde TemilolaOluwa Craig, Harish Verma, Zubairu Iliyasu, et al.
The Lancet. Global Health|December 24, 2021
Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The GambiaAdedapo O Bashorun, Mariama Badjie Hydara, Ikechukwu Adigweme, et al.
The New England Journal of Medicine|October 17, 2008
Monovalent type 1 oral poliovirus vaccine in newbornsNasr el-Sayed, Yehia el-Gamal, Ahmed-Amr Abbassy, et al.
MMWR. Morbidity and Mortality Weekly Report|September 27, 2019
Progress Toward Poliovirus Containment Implementation - Worldwide, 2018-2019Daphne B Moffett, Anna Llewellyn, Harpal Singh, et al.
Frontiers in Immunology|September 28, 2017
Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio EradicationAsghar Aghamohammadi, Hassan Abolhassani, Necil Kutukculer, et al.
Pageof 13

Showing results (121-130 of 130) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 130 results.
The Journal of Infectious Diseases|November 24, 2020
Randomized Controlled Clinical Trial of Bivalent Oral Poliovirus Vaccine and Inactivated Poliovirus Vaccine in Nigerian ChildrenBeckie N Tagbo, Harish Verma, Zubairu M Mahmud, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|December 23, 2006
Development and consideration of global policies for managing the future risks of poliovirus outbreaks: insights and lessons learned through modelingKimberly M Thompson, Radboud J Duintjer Tebbens, Mark A Pallansch, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|July 19, 2012
Expert review on poliovirus immunity and transmissionRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
The Journal of Infectious Diseases|November 12, 2020
Immunogenicity of Reduced-Dose Monovalent Type 2 Oral Poliovirus Vaccine in Mocuba, MozambiqueNilsa de Deus, Igor Paulo Ubisse Capitine, Adilson Fernando Loforte Bauhofer, et al.
Risk Analysis : an Official Publication of the Society for Risk Analysis|April 5, 2013
Review and assessment of poliovirus immunity and transmission: synthesis of knowledge gaps and identification of research needsRadboud J Duintjer Tebbens, Mark A Pallansch, Konstantin M Chumakov, et al.
The Journal of Infectious Diseases|February 25, 2016
Role of Serial Polio Seroprevalence Studies in Guiding Implementation of the Polio Eradication Initiative in Kano, Nigeria: 2011-2014Kehinde TemilolaOluwa Craig, Harish Verma, Zubairu Iliyasu, et al.
The Lancet. Global Health|December 24, 2021
Intradermal administration of fractional doses of the inactivated poliovirus vaccine in a campaign: a pragmatic, open-label, non-inferiority trial in The GambiaAdedapo O Bashorun, Mariama Badjie Hydara, Ikechukwu Adigweme, et al.
The New England Journal of Medicine|October 17, 2008
Monovalent type 1 oral poliovirus vaccine in newbornsNasr el-Sayed, Yehia el-Gamal, Ahmed-Amr Abbassy, et al.
MMWR. Morbidity and Mortality Weekly Report|September 27, 2019
Progress Toward Poliovirus Containment Implementation - Worldwide, 2018-2019Daphne B Moffett, Anna Llewellyn, Harpal Singh, et al.
Frontiers in Immunology|September 28, 2017
Patients with Primary Immunodeficiencies Are a Reservoir of Poliovirus and a Risk to Polio EradicationAsghar Aghamohammadi, Hassan Abolhassani, Necil Kutukculer, et al.
Pageof 13